“ORM 1 As a Biomarker of Increased Vascular Invasion and Decreased Sorafenib Sensitivity in Hepatocellular Carcinoma”. 2022. Biomolecules and Biomedicine 22 (6): 949-58. https://doi.org/10.17305/bjbms.2022.7268.